Paul Adepoju on Muck Rack

Paul Adepoju

(He/Him)
London
As seen in: CNN, Business Insider, Nature, Yahoo News, Yahoo Finance, New Scientist, Quartz, Scientific American, Biomed Central (BMC), Yahoo and
Covers:  Global health, science and medical research, including infectious diseases, vaccines, outbreak preparedness, biomedical innovation, health systems, access to medicines and health equity.
Science, Media, PhD | @ONA Award Winner | Byline: @Nature, @TheLancet, @NewScientist, @SciAm, @Devex, @SciDevNet

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Paul Adepoju’s Biography

Read Full Bio →

Paul Adepoju is a global health and science journalist covering biomedical research, infectious diseases, health systems, access to medicines, health financing and the politics of global health. His work has appeared in Devex, The Lancet, Nature, Scientific American, New Scientist, CNN, Health Policy Watch, BMJ and other international outlets.

A scientist-turned-journalist, Paul holds a PhD in Cell Biology and Genetics from the University of Ibadan. His reporting often examines how scientific b…

Paul Adepoju’s Journalist Portfolio

International response to hantavirus outbreak

International response to hantavirus outbreak

The Andes hantavirus outbreak linked to expedition cruise ship m/v Hondius has prompted an international publ…

View article →
No Ebola vaccines exist for the strain in the current outbreak, but scientists are developing som...

No Ebola vaccines exist for the strain in the current outbreak, but scientists are developing som...

A decade after Ebola vaccines changed outbreak response, a new epidemic in central Africa is caused by a stra…

View article →
Galaxies Wind Around a Cosmic Filament

Galaxies Wind Around a Cosmic Filament

Galaxies can collect in large filamentary structures that have-until now-been considered rigid. A new study s…

View article →
Paul Talks Science Podcast

Paul Talks Science Podcast

Podcast · Paul ADEPOJU, PhD · Welcome to "Paul Talks Science," a podcast that journeys into the ever-evolving…

View article →

Articles

Africa moves ahead with vaccine manufacturing ambitions Original

|
By Paul Adepoju
| Semafor Verified
The News Africa’s bid to build its own vaccine industry is about to face its biggest test just as Western health funding retreats. The global vaccine alliance Gavi said it will make its first cash disbursements to an African manufacturer this year, marking an important milestone as the continent seeks to produce 60% of its vaccines locally by 2040.
Open in Who Shared View Duplicates (3) Issue with article?

Review highlights gaps in South Africa's cancer care

|
By Paul Adepoju
| The Lancet Verified
South Africa's completion of its first imPACT Review has raised hopes that long-standing gaps in cancer care could be translated into a new national cancer control plan, but clinicians and advocates caution that its value depends on whether it leads to funded implementation across the country's fragmented health system.
Open in Who Shared Issue with article?

Can market shaping improve medicine access across Africa?

|
By Paul Adepoju
| Re:solve Talks
More affordable medicines do not always lead to better access. As donor funding becomes less certain and the burden of non-communicable diseases continues to rise, African countries are exploring whether market shaping can create more reliable medicine supply. Many African countries are shifting to a market shaping approach to make medical supply markets more predictable, affordable, and sustainable. Photo: Ninthgrid In theory, a successful procurement deal ends with lower prices.
Open in Who Shared Issue with article?
See all 797 licensed articles (803 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified